Stay updated on Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial
Sign up to get notified when there's something new on the Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial page.
Latest updates to the Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check14 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference4%
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has added new features for user interaction while removing extensive details about participant groups, interventions, and various data fields available for download.SummaryDifference6%
- Check36 days agoChange DetectedSeveral key health-related links have been removed, including resources from NIH and HHS, which may impact access to information on rare diseases and medications.SummaryDifference0.5%
- Check43 days agoChange DetectedThe website has been updated to version v2.12.2, adding several new resources related to rare diseases and clinical trials, including links to NIH and Dailymed, while removing the previous version v2.12.1.SummaryDifference7%
- Check50 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial page.